Taiwan FDA registration 64c5e0e40db9e1e1b5e6f3fc67e7aeba

Vitex Biochemical Tabletop Special Correction Group

TW: 維特司生化產品桌上型特殊校正組

Taiwan·Risk Class 2·ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC·Registered Apr 26, 2006 – Apr 26, 2016Cancelled

Registration details

Analysis ID: 64c5e0e40db9e1e1b5e6f3fc67e7aeba
Customs Code: DHA00601647606

Company information

Manufacturer: ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC
Manufacturer Country: United States
Authorized Representative: DKSH TAIWAN LTD.

Product details

Intended Use: Contains a special formula for the correction of bile ester enzymes, lithium and thelaphylls in the Vitas desktop biochemical system.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1150 Calibrated Products
Import Information: import

Dates and status

Registration Date: Apr 26, 2006
Expiry Date: Apr 26, 2016
Cancellation Date: Aug 14, 2018

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for Vitex Biochemical Tabletop Special Correction Group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 64c5e0e40db9e1e1b5e6f3fc67e7aeba and manufactured by ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC. The authorized representative in Taiwan is DKSH TAIWAN LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.